ArticleScientific reports2019

The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer's disease in rodents.

Guy Griebel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.